The methods to evaluate the biological significance of toxicity tests are

Answer 1

The following are some ways to evaluate the biological significance of toxicity tests:

** I. Methods related to the toxicity test (medical devices as an example)**
1. ** Observation indicators **
- ** Cell shape **: Observe the cells through a microscope. If necessary, use a staining method to check whether the cells have formed vesicles, shed cells, dissolved cells, and the integrity of the envelope. If there were obvious changes in cell form, it might indicate the existence of toxic effects. For example, normal cells have a regular shape, but when they are affected by toxic substances, they may become irregular, wrinkled, or swollen.
- ** Cell Number and Growth Status **
- ** Survival rate **: The cell survival rate can be determined by methods such as the MTT-cell toxicity test. If the cell survival rate decreased, it meant that the test substance might be toxic. Generally, a 30% decrease in cell activity was considered to be a toxic reaction.
- ** Inhibition of cell growth **: Observe whether the cells can proliferate normally. Inhibition of cell growth may be a sign of toxicity. In the toxicity test of medical devices, cultured cells would be exposed to the substances released by the medical device, and the growth of the cells would be observed. The dose-response relationship curve between the drug and the cell growth rate would be drawn to determine whether there was any inhibition of reproduction and the relationship between the degree of inhibition and the dose of the test substance.
2. ** Experimental phase and design **
- ** Initial screening experiment **: Choose 1/10 or 1/100 of the lethal dose to conduct a preliminary test to screen out potentially toxic substances.
- ** Confirming experiment **: Based on the preliminary screening experiment, further determine the concentration range of the lost activity, and more accurately assess the relationship between toxicity and dosage.

- ** Treatment of samples **: Strictly control the preparation, storage, and release of device samples to avoid unnecessary errors affecting the accurate assessment of toxicity. For example, to ensure that the sample would not produce additional toxic substances or change the original toxicity characteristics due to improper storage conditions during the experiment.
- ** Cell type selection **: Choose an appropriate cell type for the experiment to ensure that the cell type in contact with the device is the same as the cell type in contact with the human body. This can accurately reflect the possible toxic effects of the test article on the human body.
- ** Determination of experimental time and concentration range **: According to the specific experimental requirements and the characteristics of the instrument, determine the appropriate experimental time and concentration range to increase the maneuverability and repetitiveness of the experiment. Different test subjects may show toxicity at different contact times and concentration. Accurately setting these parameters is of great significance for evaluating toxicity.

** II. Methods related to special toxicity tests (such as genetic toxicity tests)**
1. ** In terms of the micro-nucleus test **
- ** Micronucleus observation **: A micronucleus is a particle outside the cell nucleus that is consistent with the nuclear dye. Its size is equivalent to 1/20 - 1/5 of the cell diameter. It is shaped like an almond or a circle. It comes from the acentric fragment formed by the break of the sperm. By observing the formation of the micronuclei, it could indicate whether the integrity of the embryos had changed, or whether the separation of the embryos had changed, indicating whether the test subject had damaged the genetic material. If the number of micronuclei increases, it may indicate that the test substance is genetically toxic.
2. ** In terms of dosage design (Take some special toxicity tests as an example)**
- In a specific experiment (such as a test to check the number and structure of aberrations in the human body), the highest dose group was set to 1/8 - 1/10 of the 50% lethal dose, the intermediate dose group was set to 1/15 of the highest dose group, and the lowest dose group was set to 1/20 of the highest dose group. A reasonable dose design was helpful in accurately assessing the toxicity of the test substance at different doses, especially when studying the dose-effect relationship.

** 3. Methods related to toxicity testing of drugs or other substances in the body (taking antibiotics as an example)**
1. ** Observation of clinical symptoms **
- Take cefotastine tablets (the first generation of cefotastine) as an example. In addition to paying attention to its antiseptic effect on specific bacteria, it was also necessary to observe the clinical reactions after use. If a pet had serious symptoms such as kidney failure in addition to the known digestive symptoms such as vomiting and nausea (in the case of kidney toxicity), it would indicate that the drug may have a greater risk of toxicity. Especially when the first-generation and second-generation cephem were used together with the antimycoside antibiotics, there would be double kidney toxicity that would lead to kidney damage, which would lead to serious consequences such as kidney failure. This was also an important aspect to evaluate the significance of toxicity.
- When evaluating the toxicity of the drug, observe whether there are symptoms that are contrary to normal physiological functions in different scenarios (such as respiratory tract, urology tract, reproductive tract, etc.). For example, enroaxin may cause skeletal hypoplasia and Achilles tendon rupture in young animals (although the probability is low). This is also part of the evaluation of drug toxicity.
2. ** Comparable analysis in animal experiments (using the analogy of the evaluation of medical devices as an example)**
- Similar to the analysis method of comparable devices in the evaluation of medical devices, the comparison method can also be used in the evaluation of drug toxicity. For example, comparing the animals that received a test drug with the animals in the control group that did not receive the test drug, and observing the changes in physiological indicators (such as blood biochemical indicators, organ function indicators, etc.). If the animals administered with the drug had abnormal liver and kidney function indicators (such as elevated alt, Creonin, etc.), while the control group was normal, it might indicate that the test drug had liver or kidney toxicity.
Read more exciting novels for free